InsiderClue
Stocks · Health care · Pharmaceutical Preparations

ALNYLAM PHARMACEUTICALS, INC.

ALNY Clue Score70
United States Fiscal year ends December CIK 0001178670 Results filed 29 Oct 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

10
Insider
Date
Role
Action
Shares
Price
Amount
David E I Pyott
1 Jun 2026
Director
Sold after exercise
17
$302.65
$5.15K
David E I Pyott
1 Jun 2026
Director
Sold after exercise
495
$300.72
$148.86K
David E I Pyott
1 Jun 2026
Director
Sold after exercise
1,222
$299.87
$366.44K
David E I Pyott
1 Jun 2026
Director
Sold after exercise
1,175
$298.91
$351.22K
David E I Pyott
1 Jun 2026
Director
Sold after exercise
921
$297.71
$274.19K
Pushkal Garg
27 Feb 2026
EVP Chief R&D
Sold after exercise
140
$334.39
$46.81K
Pushkal Garg
27 Feb 2026
EVP Chief R&D
Sold after exercise
942
$332.48
$313.20K
Pushkal Garg
27 Feb 2026
EVP Chief R&D
Sold after exercise
1,159
$331.49
$384.20K
Pushkal Garg
27 Feb 2026
EVP Chief R&D
Sold after exercise
2,259
$330.73
$747.12K
Pushkal Garg
27 Feb 2026
EVP Chief R&D
Sold after exercise
127
$328.92
$41.77K
Showing 250 of 1,128 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 460
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 213
Sales straight out of an exercise 331
Sales at will 551
Transactions with no price 0
Shares from compensation/vesting 4,289,989
Sales filed before the plan box existed 57
History held since 1 Nov 2006